These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 11263719)

  • 1. Serotonin 5-HT2A receptor binding in platelets from patients with Alzheimer's disease or vascular dementia.
    Spigset O; Wilhelmsson C; Mjörndal T; Eriksson S
    Int Psychogeriatr; 2000 Dec; 12(4):537-45. PubMed ID: 11263719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low serum sodium concentrations during treatment with citalopram in elderly patients: relationship to serum citalopram levels and to platelet serotonin 5-HT2A receptor status.
    Spigset O; Wilhelmsson C; Mjörndal T; Eriksson S
    J Clin Psychopharmacol; 2000 Oct; 20(5):582-4. PubMed ID: 11001247
    [No Abstract]   [Full Text] [Related]  

  • 3. R- and S-citalopram concentrations have differential effects on neuropsychiatric scores in elders with dementia and agitation.
    Ho T; Pollock BG; Mulsant BH; Schantz O; Devanand DP; Mintzer JE; Porsteinsson AP; Schneider LS; Weintraub D; Yesavage J; Drye LT; Munro CA; Shade DM; Lyketsos C; Bies R
    Br J Clin Pharmacol; 2016 Sep; 82(3):784-92. PubMed ID: 27145364
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Citalopram for the Treatment of Agitation in Alzheimer Dementia: Genetic Influences.
    Peters ME; Vaidya V; Drye LT; Devanand DP; Mintzer JE; Pollock BG; Porsteinsson AP; Rosenberg PB; Schneider LS; Shade DM; Weintraub D; Yesavage J; Lyketsos CG; Avramopoulos D;
    J Geriatr Psychiatry Neurol; 2016 Mar; 29(2):59-64. PubMed ID: 26303700
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of citalopram treatment on platelet serotonin function in panic disorders.
    Neuger J; Wistedt B; Sinner B; Aberg-Wistedt A; Stain-Malmgren R
    Int Clin Psychopharmacol; 2000 Mar; 15(2):83-91. PubMed ID: 10759339
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Multicenter, randomized, placebo-controlled, double-blind clinical trial of escitalopram on the progression-delaying effects in Alzheimer's disease.
    Choe YM; Kim KW; Jhoo JH; Ryu SH; Seo EH; Sohn BK; Byun MS; Bak JH; Lee JM; Yun HJ; Han MI; Woo JI; Lee DY
    Int J Geriatr Psychiatry; 2016 Jul; 31(7):731-9. PubMed ID: 26553313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Citalopram for agitation in Alzheimer's disease: design and methods.
    Drye LT; Ismail Z; Porsteinsson AP; Rosenberg PB; Weintraub D; Marano C; Pelton G; Frangakis C; Rabins PV; Munro CA; Meinert CL; Devanand DP; Yesavage J; Mintzer JE; Schneider LS; Pollock BG; Lyketsos CG;
    Alzheimers Dement; 2012; 8(2):121-30. PubMed ID: 22301195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. When and How to Treat Agitation in Alzheimer's Disease Dementia With Citalopram and Escitalopram.
    Aga VM
    Am J Geriatr Psychiatry; 2019 Oct; 27(10):1099-1107. PubMed ID: 31288974
    [TBL] [Abstract][Full Text] [Related]  

  • 9. No difference between platelet serotonin--5-HT(2A) receptors from children with and without ADHD.
    Pornnoppadol C; Friesen DS; Haussler TS; Glaser PE; Todd RD
    J Child Adolesc Psychopharmacol; 1999; 9(1):27-33. PubMed ID: 10357515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased binding to 5-HT1A and 5-HT2A receptors is associated with large vessel infarction and relative preservation of cognition.
    Elliott MS; Ballard CG; Kalaria RN; Perry R; Hortobágyi T; Francis PT
    Brain; 2009 Jul; 132(Pt 7):1858-65. PubMed ID: 19433439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet 5-HT2A-receptor-mediated induction of aggregation is not altered in major depression.
    Gómez-Gil E; Gastó C; Díaz-Ricart M; Carretero M; Salamero M; Catalán R; Escolar G
    Hum Psychopharmacol; 2002 Dec; 17(8):419-24. PubMed ID: 12457378
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of citalopram, a selective 5-HT reuptake blocker, in emotionally disturbed patients with dementia.
    Gottfries CG; Nyth AL
    Ann N Y Acad Sci; 1991; 640():276-9. PubMed ID: 1776751
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholinergic modulation of the cerebral metabolic response to citalopram in Alzheimer's disease.
    Smith GS; Kramer E; Ma Y; Hermann CR; Dhawan V; Chaly T; Eidelberg D
    Brain; 2009 Feb; 132(Pt 2):392-401. PubMed ID: 19153152
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Platelet 5-hydroxytryptamine (5-HT) transporter and 5-HT2A receptor binding after chronic hypercorticosteronemia, (+/-)-1-(2,5-dimethoxy-4-iodophenyl)-2-aminopropane administration or neurotoxin-induced depletion of central nervous system 5-HT in the rat.
    Owens MJ; Ballenger CA; Knight DL; Nemeroff CB
    J Pharmacol Exp Ther; 1996 Sep; 278(3):1040-9. PubMed ID: 8819484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serotonergic 'vulnerability' in affective disorder: a study of the tryptophan depletion test and relationships between peripheral and central serotonin indexes in citalopram-responders.
    Aberg-Wistedt A; Hasselmark L; Stain-Malmgren R; Apéria B; Kjellman BF; Mathé AA
    Acta Psychiatr Scand; 1998 May; 97(5):374-80. PubMed ID: 9611088
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Time to Response to Citalopram Treatment for Agitation in Alzheimer Disease.
    Weintraub D; Drye LT; Porsteinsson AP; Rosenberg PB; Pollock BG; Devanand DP; Frangakis C; Ismail Z; Marano C; Meinert CL; Mintzer JE; Munro CA; Pelton G; Rabins PV; Schneider LS; Shade DM; Yesavage J; Lyketsos CG;
    Am J Geriatr Psychiatry; 2015 Nov; 23(11):1127-33. PubMed ID: 26238225
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacological studies on YM992, a novel antidepressant with selective serotonin re-uptake inhibitory and 5-HT2A receptor antagonistic activity.
    Takeuchi H; Yatsugi S; Hatanaka K; Nakato K; Hattori H; Sonoda R; Koshiya K; Fujii M; Yamaguchi T
    Eur J Pharmacol; 1997 Jun; 329(1):27-35. PubMed ID: 9218680
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antidepressants for agitation and psychosis in dementia.
    Seitz DP; Adunuri N; Gill SS; Gruneir A; Herrmann N; Rochon P
    Cochrane Database Syst Rev; 2011 Feb; (2):CD008191. PubMed ID: 21328305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Changes of 5-HT2A receptor binding on platelet of patients with CAD and the effects of exercise test].
    Yang L; Lin S; Pang Y; Xu S; Jin L
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 1997 Oct; 19(5):337-41. PubMed ID: 10453517
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decreased platelet 5-hydroxytryptamin (5-HT) levels: a response to antidepressants.
    Li X; Fan Y; Xiao S; Peng S; Dong X; Zheng X; Liu CC; Li H; Xiao Z
    J Affect Disord; 2015 Nov; 187():84-90. PubMed ID: 26321259
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.